COMPLEMENT REGULATION IN THE RAT GLOMERULUS - CRRY AND CD59 REGULATE COMPLEMENT IN GLOMERULAR MESANGIAL AND ENDOTHELIAL-CELLS

被引:48
|
作者
QUIGG, RJ
MORGAN, BP
HOLERS, VM
ADLER, S
SNEED, AE
LO, CF
机构
[1] UNIV WALES COLL MED,DEPT MED BIOCHEM,CARDIFF CF4 4XN,S GLAM,WALES
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RHEUMATOL,DENVER,CO 80262
[3] NEW YORK MED COLL,DEPT MED,DIV NEPHROL,VALHALLA,NY 10595
[4] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,DIV NEPHROL,RICHMOND,VA 23298
基金
英国惠康基金;
关键词
D O I
10.1038/ki.1995.309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The complement regulators, decay accelerating factor, membrane cofactor protein, and CD59 are present in human glomeruli. Crry is the rodent analogue to the former two proteins. In this study, we examined complement regulation in cultured rat glomerular endothelial cells (GEnC) and mesangial cells (MES). Immunoprecipitation of I-125-labeled membrane proteins and Western blotting studies were performed with anti-Crry and anti-CD59. In both GEnC and MES, Crry was present as 53, 65, and 78 kD proteins. The 20 kD CD59 was apparent in GEnC. CD59 was, also present in MES, but in relatively smaller quantities. By Northern analyses, 1.8 kb CD59 mRNA was present in GEnC as well as in RNA from isolated rat glomeruli. mRNA for Crry was present in both GEnC and MES as 2.2 kb species. The functional significance of these proteins was evaluated next. Anti-Thy 1.1 IgG was used to activate the complement classical pathway in MES. To inhibit the function of the complement regulators, anti-CD59 and/or anti-Crry F(ab')(2) antibodies were added with anti-Thy 1.1. Inhibition of Crry function led to enhanced cytotoxicity, while there was no effect when CD59 function was inhibited. The complement alternative pathway was studied by adding complement in Mg-EGTA buffer. Inhibition of Crry led to productive alternative pathway activation, which was accentuated by anti-CD59 when Crry was incompletely inhibited. Alternative pathway regulation was also evaluated in GEnC. Inhibition of CD59 function alone had no effect in GEnC, while inhibition of Crry led to significant cytotoxicity from alternative pathway activation. Under conditions in which Crry was inactive, inhibition of CD59 further enhanced cytotoxicity. Therefore, Crry is present in both GEnC and MES and restricts the complement alternative pathway in both cell types. Crry also regulates the classical pathway in MES. CD59 is present and functionally active in GEnC, while it appears to have a minor role in MES.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 50 条
  • [21] Identification of mutations in rat CD59 that increase the complement regulatory activity
    Hinchliffe, SJ
    Morgan, BP
    BIOCHEMISTRY, 2000, 39 (19) : 5831 - 5837
  • [22] TRANSFECTED CD59 PROTECTS MESANGIAL CELLS (MC) FROM INJURY-INDUCED BY ANTIBODY AND COMPLEMENT (C)
    NANGAKU, M
    MEEK, R
    PIPPIN, J
    GORDON, K
    JOHNSON, RJ
    MORGAN, BP
    COUSER, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 845 - 845
  • [23] Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59
    Li, Qing
    Nacion, Kristine
    Bu, Hong
    Lin, Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 382 (01) : 223 - 226
  • [24] CYTOKINE-MEDIATED REGULATION OF THE SURFACE EXPRESSION OF COMPLEMENT REGULATORY PROTEINS, CD46(MCP), CD55(DAF), AND CD59 ON HUMAN VASCULAR ENDOTHELIAL-CELLS
    MOUTABARRIK, A
    NAKANISHI, I
    NAMIKI, M
    HARA, T
    MATSUMOTO, M
    ISHIBASHI, M
    OKUYAMA, A
    ZAID, D
    SEYA, T
    LYMPHOKINE AND CYTOKINE RESEARCH, 1993, 12 (03): : 167 - 172
  • [25] PROTECTION OF PORCINE AORTIC ENDOTHELIAL-CELLS FROM COMPLEMENT-MEDIATED CELL-LYSIS AND ACTIVATION BY RECOMBINANT HUMAN CD59
    KENNEDY, SP
    ROLLINS, SA
    BURTON, WV
    SIMS, PJ
    BOTHWELL, ALM
    SQUINTO, SP
    ZAVOICO, GB
    TRANSPLANTATION, 1994, 57 (10) : 1494 - 1501
  • [26] PERMANENT EXPRESSION OF HUMAN CD59 AND/OR DECAY-ACCELERATING FACTOR BY RAT ENDOTHELIAL-CELLS CONFERS PROTECTION FROM HUMAN COMPLEMENT-MEDIATED LYSIS
    CHARREAU, B
    CASSARD, A
    TESSON, L
    LEMAUFF, B
    BLANCHARD, D
    LUBLIN, D
    SOULILLOU, JP
    ANEGON, I
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 336 - 337
  • [27] IDENTIFICATION OF COMPLEMENT RECEPTOR (CRI) ON RAT GLOMERULAR MESANGIAL CELLS - EFFECTS OF COMPLEMENT ON PROSTAGLANDIN SYNTHESIS
    STORK, JE
    DUNN, MJ
    EMANCIPATOR, SN
    CLINICAL RESEARCH, 1985, 33 (02): : A589 - A589
  • [28] Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects
    Davies, CS
    Harris, CL
    Morgan, BP
    IMMUNOLOGY, 2005, 114 (02) : 280 - 286
  • [29] Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells
    Brasoveanu, LI
    Altomonte, M
    Fonsatti, E
    Colizzi, F
    Coral, S
    Nicotra, MR
    Cattarossi, I
    Cattelan, A
    Natali, PG
    Maio, M
    LABORATORY INVESTIGATION, 1996, 74 (01) : 33 - 42
  • [30] Down-regulation of CD59 sensitizes prostate carcinoma cells to complement attack and inhibits proliferation
    Li, Wenhan
    Schultz, Stefan
    Geiss, Nicolas
    Kirschfink, Michael
    MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3948 - 3948